Results for "Understanding Pharmaceutical Distribution"
HDA Addresses DSCSA Data-Related Challenges In Healthcare Packaging Op-Ed
With the end of the 10-year-implementation of the Drug Supply Chain Security Act (DSCSA) fast approaching and significant work remaining for the supply chain, HDA’s Anita Ducca, Senior Vice President, Regulatory Affairs, and Elizabeth Gallenagh, General Counsel and Senior Vice President, Supply Chain Integrity co-authored a piece for Healthcare Packaging that examines the progress toward, challenges impacting and recommendations and requirements for full implementation.
Chip Davis Shares HDA’s 2025 Policy Priorities in Annual Chain Drug Review Column
In his annual “Health Care Outlook” column featured in Chain Drug Review, HDA’s President and CEO Chip Davis outlines a series of key policy priorities for healthcare distributors in 2025, as well as some challenges he expects the industry to face.
Healthcare Distributors Are Supporting Under-Resourced Communities During COVID-19
On October 7, HDA launched a three-part series to showcase how the distribution industry is helping create healthier communities through philanthropy, employee activism, partnerships with nonprofit organizations and more. This week, we are sharing how HDA distributors have acted with urgency to meet the unprecedented needs of Americans, and individuals across the globe, during the COVID-19 pandemic.